
Tribose 0.2mg Tablet
Marketer
Ordain Health Care Global Pvt Ltd
Salt Composition
Voglibose (0.2mg)
Overview Tribose 0.2mg Tablet
DiaBeta 0.2mg tablets are prescribed for the management of type 2 diabetes. This medication helps regulate elevated blood glucose levels following meals, particularly when dietary modifications and other similar medications prove insufficient. DiaBeta 0.2mg tablets should be administered immediately prior to eating. Dosage and frequency are determined individually by your physician to optimize blood sugar control. Discontinuation should never occur without medical consultation, as abrupt cessation may lead to dangerously high blood sugar, potentially resulting in severe complications such as renal impairment and vision loss. This medication forms part of a comprehensive treatment plan incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is essential during treatment. Commonly reported side effects include gas, abdominal discomfort, decreased appetite, constipation, and diarrhea. Report any persistent or bothersome side effects to your doctor. While DiaBeta 0.2mg tablets themselves do not induce hypoglycemia (low blood sugar), concurrent use with other antidiabetic agents (especially insulin or sulfonylureas) can increase this risk. Treatment for hypoglycemic episodes requires simple glucose; table sugar is ineffective in these circumstances. Prior to commencing treatment, inform your doctor of any kidney or liver conditions. This medication is contraindicated in patients with bowel ulcers or inflammation (e.g., ulcerative colitis or Crohn's disease). Pregnant or lactating individuals should seek medical advice before use. Always disclose all other medications to ensure medication safety. Limit alcohol consumption while taking DiaBeta 0.2mg tablets to minimize the risk of hypoglycemia.
Primary Ingredients of Tribose 0.2mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Tribose 0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Tribose 0.2mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 0.2mg Tribose tablet whole; do not crush, chew, or fracture it. Administer on an empty stomach.
Common Side effects of Tribose 0.2mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Tribose 0.2mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the 0.2mg Tribose tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
How Tribose 0.2mg Tablet works:
Diabetase 0.2mg tablets help manage diabetes by blocking the digestive enzymes that convert complex carbohydrates into readily absorbed glucose. This action minimizes post-meal spikes in blood sugar.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Tribose 0.2mg Tablet is inadvisable.
PregnancySAFE IF PRESCRIBED
The use of Tribose 0.2mg tablets during pregnancy is generally deemed safe. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; however, clinical data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Using Tribose 0.2mg tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Tribose 0.2mg tablets.
KidneyCAUTION
Patients with severe kidney impairment should use Tribose 0.2mg tablets cautiously. A dose modification of Tribose 0.2mg tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Tribose 0.2mg tablets. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Tribose 0.2mg Tablet :
Omit any missed Tribose 0.2mg Tablet dose and resume your usual regimen. Avoid taking a double dose.
Facts to Know About Tribose 0.2mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Alpha-glucosidase inhibitors |
